Jay Olson
Stock Analyst at Oppenheimer
(4.06)
# 539
Out of 5,090 analysts
243
Total ratings
45.13%
Success rate
14.25%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDGL Madrigal Pharmaceuticals | Maintains: Outperform | $600 → $650 | $591.06 | +9.97% | 12 | Nov 20, 2025 | |
| TERN Terns Pharmaceuticals | Maintains: Outperform | $20 → $17 | $27.21 | -37.52% | 3 | Oct 22, 2025 | |
| IBIO iBio, Inc. | Initiates: Outperform | $5 | $1.28 | +292.16% | 1 | Oct 21, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $84 → $90 | $81.64 | +10.24% | 4 | Oct 8, 2025 | |
| IMRX Immuneering | Maintains: Outperform | $21 → $30 | $6.75 | +344.77% | 3 | Sep 25, 2025 | |
| BCYC Bicycle Therapeutics | Maintains: Outperform | $48 → $44 | $7.19 | +511.96% | 4 | Aug 11, 2025 | |
| MNMD Mind Medicine (MindMed) | Reinstates: Outperform | $25 | $12.48 | +100.40% | 1 | Aug 4, 2025 | |
| ATAI Atai Beckley | Initiates: Outperform | $14 | $4.39 | +218.91% | 1 | Jul 29, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $97 → $115 | $191.83 | -40.05% | 2 | Jul 8, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Perform | $19 → $22 | $26.59 | -17.25% | 15 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $11.30 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $4.23 | +1,438.46% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $65 | $1.87 | +3,385.25% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $2.04 | +538.82% | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $78.51 | -4.46% | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $90 | $57.50 | +56.54% | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $42 | $20.30 | +106.90% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | $41 → $33 | $44.40 | -25.67% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $40 | $9.77 | +309.63% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $20 | $3.56 | +461.80% | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $6.37 | +370.96% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $270 → $255 | $181.82 | +40.25% | 25 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $81 → $82 | $100.48 | -18.39% | 14 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $10 | $22.72 | -55.99% | 4 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $138 | $38.86 | +255.12% | 8 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $8 | $3.48 | +130.22% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $380 | $340.33 | +11.66% | 23 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $216 → $219 | $153.75 | +42.44% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $12 | $2.44 | +391.80% | 6 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 | $4.34 | +314.75% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 | $8.81 | +1,035.07% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $102 → $95 | $58.85 | +61.43% | 6 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $1.20 | +1,983.33% | 1 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 | $1.75 | +412.88% | 4 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,200 → $500 | $1.61 | +30,955.90% | 4 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $25 → $21 | $14.17 | +48.20% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $3.96 | - | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $84 | $18.07 | +364.86% | 1 | Mar 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $1.61 | - | 3 | Jul 11, 2017 |
Madrigal Pharmaceuticals
Nov 20, 2025
Maintains: Outperform
Price Target: $600 → $650
Current: $591.06
Upside: +9.97%
Terns Pharmaceuticals
Oct 22, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $27.21
Upside: -37.52%
iBio, Inc.
Oct 21, 2025
Initiates: Outperform
Price Target: $5
Current: $1.28
Upside: +292.16%
Ionis Pharmaceuticals
Oct 8, 2025
Maintains: Outperform
Price Target: $84 → $90
Current: $81.64
Upside: +10.24%
Immuneering
Sep 25, 2025
Maintains: Outperform
Price Target: $21 → $30
Current: $6.75
Upside: +344.77%
Bicycle Therapeutics
Aug 11, 2025
Maintains: Outperform
Price Target: $48 → $44
Current: $7.19
Upside: +511.96%
Mind Medicine (MindMed)
Aug 4, 2025
Reinstates: Outperform
Price Target: $25
Current: $12.48
Upside: +100.40%
Atai Beckley
Jul 29, 2025
Initiates: Outperform
Price Target: $14
Current: $4.39
Upside: +218.91%
Praxis Precision Medicines
Jul 8, 2025
Maintains: Outperform
Price Target: $97 → $115
Current: $191.83
Upside: -40.05%
ACADIA Pharmaceuticals
Jun 26, 2025
Maintains: Perform
Price Target: $19 → $22
Current: $26.59
Upside: -17.25%
May 27, 2025
Downgrades: Perform
Price Target: n/a
Current: $11.30
Upside: -
May 21, 2025
Initiates: Outperform
Price Target: $65
Current: $4.23
Upside: +1,438.46%
May 15, 2025
Maintains: Outperform
Price Target: $80 → $65
Current: $1.87
Upside: +3,385.25%
May 14, 2025
Maintains: Outperform
Price Target: $15 → $13
Current: $2.04
Upside: +538.82%
May 8, 2025
Maintains: Outperform
Price Target: $70 → $75
Current: $78.51
Upside: -4.46%
Mar 14, 2025
Upgrades: Outperform
Price Target: $90
Current: $57.50
Upside: +56.54%
Mar 3, 2025
Maintains: Outperform
Price Target: $50 → $42
Current: $20.30
Upside: +106.90%
Jan 24, 2025
Downgrades: Perform
Price Target: $41 → $33
Current: $44.40
Upside: -25.67%
Jan 13, 2025
Maintains: Outperform
Price Target: $60 → $40
Current: $9.77
Upside: +309.63%
Dec 11, 2024
Maintains: Outperform
Price Target: $80 → $20
Current: $3.56
Upside: +461.80%
Dec 6, 2024
Initiates: Outperform
Price Target: $30
Current: $6.37
Upside: +370.96%
Oct 31, 2024
Maintains: Outperform
Price Target: $270 → $255
Current: $181.82
Upside: +40.25%
Oct 30, 2024
Maintains: Outperform
Price Target: $81 → $82
Current: $100.48
Upside: -18.39%
Oct 17, 2024
Maintains: Outperform
Price Target: $9 → $10
Current: $22.72
Upside: -55.99%
Sep 25, 2024
Reiterates: Outperform
Price Target: $138
Current: $38.86
Upside: +255.12%
Aug 14, 2024
Assumes: Outperform
Price Target: $8
Current: $3.48
Upside: +130.22%
Aug 7, 2024
Maintains: Outperform
Price Target: $380
Current: $340.33
Upside: +11.66%
Aug 2, 2024
Maintains: Outperform
Price Target: $216 → $219
Current: $153.75
Upside: +42.44%
Jun 18, 2024
Maintains: Perform
Price Target: $12
Current: $2.44
Upside: +391.80%
May 15, 2024
Maintains: Outperform
Price Target: $18
Current: $4.34
Upside: +314.75%
May 15, 2024
Maintains: Outperform
Price Target: $100
Current: $8.81
Upside: +1,035.07%
May 10, 2024
Maintains: Outperform
Price Target: $102 → $95
Current: $58.85
Upside: +61.43%
Apr 12, 2024
Initiates: Outperform
Price Target: $25
Current: $1.20
Upside: +1,983.33%
Mar 27, 2024
Maintains: Outperform
Price Target: $9
Current: $1.75
Upside: +412.88%
Nov 30, 2023
Maintains: Outperform
Price Target: $1,200 → $500
Current: $1.61
Upside: +30,955.90%
Nov 22, 2023
Maintains: Perform
Price Target: $25 → $21
Current: $14.17
Upside: +48.20%
Oct 13, 2022
Downgrades: Perform
Price Target: n/a
Current: $3.96
Upside: -
Mar 20, 2018
Maintains: Outperform
Price Target: $70 → $84
Current: $18.07
Upside: +364.86%
Jul 11, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1.61
Upside: -